Browse studies

Find your next paid study

27,306 recruiting studies available now

Post-market Evaluation of LumiSystem: Intraoperative Margin Performance and Clinical Utility

This is a minimal risk post-market registry study conducted at participating clinical institutions that are utilizing LumiSystem consistent with the U.S. Food …

Breast Cancer

Estimated

~$10 – $1,050

Actual pay is set by the research site.

Lumicell, Inc.NCT07616856

Observational

A Prospective, Multi-center, Single-blind, Randomized (1:1), Non-inferiority Study Comparing Clinical Outcomes of the Virtue® Sirolimus AngioInfusion™ Balloon (SAB) to the AGENT™ Paclitaxel Drug-Coated Balloon (DCB) in the Treatment of Coronary Artery In-stent Restenosis (ISR).

A prospective, multi-center, single-blind, randomized (1:1), non-inferiority study comparing clinical outcomes of the Virtue® Sirolimus AngioInfusion™ Balloon …

Coronary Artery Disease

Estimated

~$10 – $1,050

Actual pay is set by the research site.

Orchestra BioMed, IncNCT07045194

Phase 2

ROSETTA CRC-203: A Blinded, Randomized Phase 2/3 Study of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer

The purpose of this study is to evaluate the safety and efficacy of pumitamig in combination with chemotherapy versus bevacizumab in combination with chemother…

Untreated, Unresectable, or Metastatic Colorectal Cancer

Estimated

~$75 – $3,000

Actual pay is set by the research site.

Bristol-Myers SquibbNCT07221357

Observational

A Randomized Controlled Trial of Brief Behavioral Activation for Older Adult Cancer Survivors (BBA-OACs)

The purpose of this study is to find out if a psychotherapy method called brief behavioral activation (BBA) can improve depression, anxiety, and overall well-b…

Cancer Survivors

Estimated

~$10 – $750

Actual pay is set by the research site.

Memorial Sloan Kettering Cancer CenterNCT07768449

Observational

GORE® TAG® Thoracic Branch Endoprosthesis Zone 0/1 Post-Approval Study

A prospective multi-center post-market study collecting outcomes through at least 5-years and up to 10-years post procedure for subjects treated with the TBE D…

Aortic Arch DissectionAortic Arch Aneurysm

Estimated

~$10 – $1,125

Actual pay is set by the research site.

W.L.Gore & AssociatesNCT07166133

Real-World Treatment of Extracranial Carotid Artery Disease With the ENROUTE™ Transcarotid Neuroprotection System (ENTRUST)

The ENTRUST registry's objective is to collect real-world data (RWD) and health economic data on the ENROUTE™ Transcarotid Neuroprotection System (ENROUTE™ Tra…

Extracranial Carotid Artery DiseaseTCARTranscarotid Artery Revascularization

Estimated

~$10 – $1,050

Actual pay is set by the research site.

Boston Scientific CorporationNCT07455747

Phase 2

An Open-label, Single-Arm, Phase 2 Study to Evaluate Enfortumab Vedotin Plus Pembrolizumab for Bladder Preservation in Participants With Muscle-invasive Bladder Cancer (EV-209)

People with a type of bladder cancer called muscle-invasive bladder cancer have cancer that has spread into the muscle wall of the bladder. The standard treatm…

Muscle-invasive Bladder Cancer

Estimated

~$75 – $2,800

Actual pay is set by the research site.

Astellas Pharma Global Development, Inc.NCT07475806

Phase 2

A Randomized, Double-blind, Vehicle-controlled Phase 2 Study to Evaluate Efficacy, Safety, and Tolerability of Topically Applied TCP-25 in Patients With Epidermolysis Bullosa

This is a Phase 2, double-blind, randomized, vehicle-controlled study designed to evaluate efficacy, safety, and tolerability of topically applied TCP-25 gel i…

Epidermolysis Bullosa (EB)Dystrophic Epidermolysis BullosaJunctional Epidermolysis Bullosa

Estimated

~$75 – $3,000

Actual pay is set by the research site.

Xinnate ABNCT06594393

Improving Implementation of Guideline-Recommended LDL-C Management in High-Risk Cardiovascular Patients: A Multilevel Implementation Science Study

The goal of this observational study is to learn whether implementing evidence-based strategies in cardiology practices can improve guideline-recommended low-d…

ASCVD

Estimated

~$10 – $1,125

Actual pay is set by the research site.

Cardiology Consultants of PhiladelphiaNCT07883564

A Study of Longitudinal Neurocognitive and Neuroimaging Evaluations for Adult Patients With Lymphoma Receiving CD19 CAR T Cell Therapy

The purpose of this study is to learn about possible changes in cognitive (mental) abilities, such as memory skills and concentration, and in brain anatomy (st…

Lymphoma Receiving CAR-T Therapy

Estimated

~$10 – $750

Actual pay is set by the research site.

Memorial Sloan Kettering Cancer CenterNCT04107285

Observational

Dental Cleaning to Prevent Chronic Graft-Versus-Host Disease

This clinical trial evaluates the feasibility and effectiveness of a post-transplant dental cleaning for the prevention of chronic graft versus host disease (G…

Chronic Graft Versus Host DiseaseAcute Graft Versus Host DiseaseHematopoietic and Lymphatic System Neoplasm

Estimated

~$10 – $750

Actual pay is set by the research site.

Fred Hutchinson Cancer CenterNCT07535008

Phase 3

A Randomized, Multicenter, Phase III Trial of Tacrolimus/Methotrexate/Ruxolitinib Versus Post-Transplant Cyclophosphamide/Tacrolimus/Mycophenolate Mofetil in Non-Myeloablative/Reduced Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation

The purpose of this study is to assess Tacrolimus/Methotrexate/Ruxolitinib versus Post-Transplant Cyclophosphamide/Tacrolimus/Mycophenolate Mofetil in Non-Myel…

Graft-versus-host Disease (GVHD)

Estimated

~$50 – $2,100

Actual pay is set by the research site.

Incyte CorporationNCT06615050